Abstract: A process for consolidating a hydrogel including alginate and gelatin, which includes a step of consolidation by crosslinking of the hydrogel using a suitable solution, in order to give it particularly advantageous mechanical properties. Also, the use of this crosslinking solution for consolidating the structure of a hydrogel including alginate and gelatin, and to a hydrogel obtained by this process. Additionally, a process for consolidating the structure of a hydrogel including alginate and gelatin, this process including preparing the hydrogel, shaping it, then bringing it into contact with suitable consolidation agents. Further, the hydrogel obtained by this process. In all these aspects, the hydrogel can further include fibrinogen and/or living cells.

Abstract: The present invention relates to a method for assisting with lymphoma prognosis. The prognosis of therapeutic response of patients with lymphoma is difficult. Based on a study of advanced stage DLBCL patients, the inventors showed that medical imaging such as 18F-FDG-PET/CT can provide a prognostic radiomic signature combining metrics reflecting tumor dissemination and tumor burden. In another aspect, the invention relates to a computer software comprising instructions to implement at least a part of a method according to the invention. In yet another aspect, the invention relates to a computer-readable non-transient recording medium on which a software is registered to implement a method according to the invention.

Abstract: The present invention concerns a reactor for the conversion of carbon dioxide or carbon monoxide into hydrocarbon and/or alcohol comprising a support made from an electrically and thermally conductive material, forming the wall or walls of at least one longitudinal channel that passes through the support and also acting as the cathode of the reactor, at least one wire electrode forming an anode of the reactor, and extending within each longitudinal channel, and being arranged at a distance from the wall or walls of the longitudinal channel, each wire electrode optionally being covered with an electrically insulating layer along the part of the wire electrode extending within the longitudinal channel, a catalyst capable of catalysing a conversion reaction for the conversion of carbon dioxide or carbon monoxide into hydrocarbon and/or alcohol, the catalyst being situated between the wire electrode and the wall or walls of each longitudinal channel.

Abstract: The invention relates to a NCO-terminated urethane preprolymer based on at least a polyol oligomer and a diisocyanate, wherein the polyol oligomer is polyhydroxyalkanoate-diol oligomers (oligoPHA-diol) having a hydroxyl value of more than or equal to 149 mgKOH/g, and the diisocyanate is selected from the list consisting of 1,4-butane diisocyanate (BDI), hexamethylene diisocyanate (6-HDI), dimeryl diisocyanate (DDI), pentamethylene diisocyanate (PDI), L-lysine diisocyanate (LDI), 1,7-heptamethylene diisocyanate (7-HDI), and mixtures thereof. The invention also relates to a method for preparing such a NCO-terminated urethane prepolymer and for a method for preparing polyhydroxyalkanoate-diol oligomers (oligoPHA-diol). The invention also relates to a hemostatic tissue adhesive composition and a hemostatic tissue adhesive. The invention also relates to a kit for the preparation of a hemostatic tissue adhesive.

Abstract: A method for maximizing the current produced by a bifacial photovoltaic solar module including a plurality of cells, each having at least two stacked and series-connected junctions, the module being capable of orientation and including a device for driving its orientation with respect to the sun. The method includes an algorithm including measuring the module's irradiance at the upper face (Ai) on its upper photoactive face, reflective irradiance (Ar) on its lower photoactive face in its initial orientation, and initial current I from the irradiances Ai and Ar, and calculating currents Ijg generated by the stacked junctions from the cells' physical characteristics and I, calculating an optimized theoretical orientation for which equalization and maximization of the theoretical currents Ijtmax is obtained, and positioning the module in the theoretical orientation when an imbalance between Ijtmax and Ijg is greater than a threshold value dIjmax. A module designed for this method.

Abstract: The present invention relates to a method for preparing p-menthane-3,8-diol, characterised in that it comprises the following steps: a. preparation of an aqueous solution comprising between 0.05% and 5% by mass, preferably between 0.05% and 2% by mass, preferentially between 0.05% and 1% by mass, even more preferentially between 0.05% and 0.

Abstract: A fluidic system for producing extracellular vesicles from producer cells, including at least one container, a liquid medium contained by the container and producer cells, characterised in that it also includes microcarriers suspended in the liquid medium, the majority of producer cells being adherent to the surface of the microcarriers, and a liquid medium agitator, the agitator and the dimensions of the container being adapted to control a turbulent flow of the liquid medium in the container.

Abstract: Despite the notion that human CD8+ T cells are the final mediators of autoimmune ?-cell destruction in type 1 diabetes (T1D), none of their target epitopes has been demonstrated to be naturally processed and presented by ? cells. The inventors therefore performed an epitope discovery study combining HLA Class I peptidomics and transcriptomics strategies. Inflammatory cytokines increased ?-cell peptide presentation in vitro, paralleling upregulation of HLA Class I expression. Peptide sources included known ?-cell antigens and several insulin granule proteins. Urocortin 3 was identified as a novel ?-cell antigen, which was processed into HLA-A2- and HLA-A3-restricted epitopes recognized by circulating naive CD8+ T cells in type 1 diabetic and healthy donors. Accordingly, the present invention relates to antigenic peptides derived from urocortin-3 and uses thereof for the diagnosis and treatment of T1D.

Abstract: A magnetic tunnel junction includes at least one free layer, at least one reference layer, and at least one tunnel barrier separating the free layer and the reference layer, wherein the free layer is an inhomogeneous granular layer including at least two grains, each grain of the at least two grains being sensibly magnetically decoupled from the other adjacent grains of the at least two grains.

Abstract: The invention relates to a synthetic sialoside presenting the formula (I): Neu5-Ac-?2-6-R1(R2)[GlcNAc?1-4]n-GlcNAc Formula wherein: -GlcNAc is N-acetylglucosamine; -GlcNAc?1-4 ia a N-acetylglucosamine unit linked with a ?1-4 link; -n is a superior or equal to 1; -R1 is a glycan structure comprising at least one galactose (Gal); and -R2 is chosen among the following groups: H, fucose linked with a ?1-3 link (Fuc?1-3) or a1-4 link (Fuc?1-4).

Abstract: Multi-rotor hydraulic drone (1) comprising: —a plurality of hydraulic motors (6) each receiving a pressurised fluid, —propellers (5) driven by the hydraulic motors (6), —at least one hydraulic pump (10) driven by at least one motor (11) for pressurising the fluid, —a system for supplying the hydraulic motors (6) with pressurised fluid, —a flight controller (14) for controlling the supply system according to the desired rotation speed for the hydraulic motors (6), the supply system comprising several channels (35; 36; 37; 38) for adjusting the power of at least one portion of the hydraulic motors (6).

Abstract: A negative electrode active material for a lithium-ion battery has the following formula (I): Li1-xOHFe1+xS (I). x varies from 0.00 to 0.25, preferably from 0.05 to 0.20.

Abstract: The invention relates to an isolated non-naturally occurring protein comprising the amino acid sequence as set forth in SEQ ID NO: 1, and wherein the amino acid in position 8, 47, 209 and/or 354 is substituted by any amino acid different from the amino acid indicated at that position in said sequence SEQ ID NO: 1.

Abstract: The present invention relates to a genetically engineered plant in which the G-box motif has been inactivated, thereby inhibiting the thermosensory response, and methods for preparing such a plant.

Abstract: According to one aspect, the invention relates to a system (101) for in vivo, full-field interference microscopy imaging of a scattering three-dimensional sample.

Abstract: The invention describes a device (10) for dispensing microbubbles (30) for cell sonoporation, comprising: a tube configured to receive a vial (20) containing a solution (26) of microbubbles (30), at least two catheters (11, 12) arranged inside the tube and opening into the vial (20) when the latter is received by the tube, wherein, when the first catheter (11) is connected to a first air injection source, air can be injected into the vial (20) via the first catheter so as to generate an overpressure therein, the microbubbles (30) contained in the vial (20) entering the second catheter (12) and moving toward its second end (122). The invention also relates to a sonoporation device, a sonoporation process and a computer program product.

Abstract: The present invention relates to a microfluidic chip capable of attracting and trapping a specific biological element, said chip comprising: a reservoir (1) consisting of a matrix comprising a chemoattractant compound capable of attracting the biological element, and at least one array of microchannels (2) arranged between the reservoir (1) and the external medium (3) of the chip and enabling the chemoattractant compound to pass towards said medium and the biological element present in said medium to pass towards the reservoir (1), characterized in that each microchannel is in the form of a harpoon comprising at least two arrows spaced apart longitudinally and directed towards the reservoir, in which each arrow comprises two branches each having a free end forming an acute angle of between 10° and 80°, and in which each arrow comprises two openings (7) communicating with a longitudinal part of the microchannel and having a width of between 5 ?m and 30 ?m.

Abstract: The present invention relates to a virus-derived particle comprising one or more Cas protein(s), as well as to kits and methods using the same for altering a target nucleic acid.

Abstract: A novel Trichoderma harzanium strain, filed on Jun. 12, 2018 with the CNCM (Collection Nationale de Cultures de Micro-organismes), 25-28 rue du Docteur Roux, 75724 Paris Cedex 15, under number CNCM I-5327. Also, the use of this Trichoderma harzanium strain to control fusarium head blight in cereals selected from wheat, Brachypodium distachyon, triticale, oats and rye, and more particularly to combat fusarium head blight in wheat.

Abstract: The present invention relates to a novel pharmaceutical use of bromide, i.e. the treatment of autism spectral disorder (ASD).